A Novel Gastrodin Derivative with Neuroprotection Promotes NGF-Mimic Activity by Targeting INSR and ACTN4 to Activate PI3K/Akt Signaling Pathway in PC12 Cells
Gastrodin (gas) has been shown to promote neuroprotection and reverse Alzheimer’s disease (AD) pathology. However, its high effective dose limits its potential in treating AD. In this study, a bioassay system using PC12 cells and the nerve growth factor (NGF)-mimic effect was employed to investigate...
Saved in:
| Main Authors: | Jiayuan Zeng, Jianxia Mo, Makoto Muroi, Hiroyuki Osada, Lan Xiang, Jianhua Qi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-03-01
|
| Series: | Antioxidants |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-3921/14/3/344 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gastrodin: a potential natural product for the prevention and treatment of cerebral ischemia-reperfusion injury
by: Wenxiu Qin, et al.
Published: (2025-05-01) -
Pharmacological effects of gastrodin: Insight into neurological diseases and mechanism in ferroptosis and pyroptosis
by: Xue Zheng, et al.
Published: (2025-03-01) -
The frequency of the ACTN3 polymorphism in Brazil: a systematic review and meta-analysis
by: Valmir Oliveira Silvino, et al.
Published: (2025-04-01) -
Impact of ACTN3 R577X Polymorphism on Muscle Damage Susceptibility Following Aerobic or Strength Exercises: A Systematic Review
by: Alexandre de S. e Silva, et al.
Published: (2025-05-01) -
The protective effects of gastrodin on neurological disorders: an update and future perspectives
by: Zhouying Shi, et al.
Published: (2024-12-01)